Phase II study of epirubicin and vinorelbine with granulocyte colony- stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer

C. Nisticò, C. Garufi, S. Barni, L. Frontini, D. A P Gallà, D. Giannarelli, A. Vaccaro, A. M. D'Ottavio, E. Terzoli

Research output: Contribution to journal › Article › peer-review

Fingerprint Dive into the research topics of 'Phase II study of epirubicin and vinorelbine with granulocyte colony- stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences